Back
Canopy Growth Vs. Acasti Pharma Industry Stock Comparison
Sell
35
CGC
Canopy Growth
Last Price:
9.05
Seasonality Move:
-10.38%
Sell
50
ACST
Acasti Pharma
Last Price:
2.76
Seasonality Move:
19.61%
Sell
35
Canopy Growth (CGC)
is a Sell
Is Canopy Growth a Buy, Sell or Hold?
- The current Canopy Growth [CGC] share price is $9.05. The Score for CGC is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- CGC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Acasti Pharma (ACST)
is a Sell
Is Acasti Pharma a Buy, Sell or Hold?
- The current Acasti Pharma [ACST] share price is $2.76. The Score for ACST is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- ACST is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CGC Stock Price Chart
What is Canopy Growth's stock price today?
-
The Canopy Growth share price today is $9.05
The current trend is moderately bearish and CGC is experiencing selling pressure, which indicates risk of future bearish movement.
ACST Stock Price Chart
What is Acasti Pharma's stock price today?
-
The Acasti Pharma share price today is $2.76
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACST is experiencing selling pressure, which indicates risk of future bearish movement.
CGC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.63 | Buy |
Relative Strength Index (14 RSI): | 50.59 | Buy |
Chaikin Money Flow: | -6727868 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.38 - 10.7) | Buy |
Bollinger Bands (100): | (3.28 - 8.36) | Buy |
ACST Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.11 | Sell |
Relative Strength Index (14 RSI): | 35.91 | Sell |
Chaikin Money Flow: | -2320 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.79 - 3.27) | Sell |
Bollinger Bands (100): | (2.53 - 3.37) | Sell |
CGC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.9 | Sell |
20-day SMA: | 9.09 | Sell |
50-day SMA: | 7.23 | Buy |
200-day SMA: | 6.1 | Buy |
8-day EMA: | 9.63 | Sell |
20-day EMA: | 9.27 | Sell |
50-day EMA: | 7.87 | Buy |
200-day EMA: | 8.36 | Buy |
ACST Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.88 | Sell |
20-day SMA: | 2.94 | Sell |
50-day SMA: | 3.22 | Sell |
200-day SMA: | 2.62 | Buy |
8-day EMA: | 2.85 | Sell |
20-day EMA: | 2.95 | Sell |
50-day EMA: | 3.04 | Sell |
200-day EMA: | 2.92 | Sell |
Canopy Growth Earnings Growth & CGC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.01 per share, an increase this year of $6.78 per share, and an increase next year of $1.55 per share.
Acasti Pharma Earnings Growth & ACST Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.07 per share, an increase this year of $1.16 per share, and an increase next year of $0.34 per share.
Canopy Growth Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Acasti Pharma Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |